As of Q3'26 (2026-01-02), GEN reported a diluted EPS of 0.31 USD, marking the highest value observed since Q4'23. The year-over-year EPS growth for this latest quarter stands at 19.2%, indicating a notable acceleration compared to the previous quarters. Over the period from Q4'23 to Q3'26, GEN's diluted EPS exhibited significant volatility, with a sharp decline from 1.46 USD in Q4'23 to a low of 0.21 USD in Q2'26, before rebounding to 0.31 USD in Q3'26. The EPS growth rate also fluctuated, with periods of negative growth—most notably in Q4'24 (-85.6%)—followed by a gradual recovery and positive growth in the latest quarter. This trend suggests a challenging earnings environment in 2024 and 2025, with signs of stabilization and renewed growth emerging by early 2026.